Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

July 2014

P&T Committee Updates 


At a March 3, 2014 meeting, the Harvard Pilgrim Pharmacy & Therapeutics Committee reviewed several medications and decided the following.

P&T Committee Review and Decisions

Name  Indication  Decision
Duavee
(conjugated estrogens + bazedoxifene) 
Duavee is used to prevent osteoporosis and treat moderate to severe vasomotor symptoms of menopause in postmenopausal women (with a uterus).  Continued coverage at
• Tier 3 for 3-Tier formulary
• Tier 4 for 4-Tier formulary
• Tier 3 for Medicare Part D
Farxiga
(dapagliflozin) 
Farxiga and Invokana are used in addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes.  Continued coverage at
• Tier 3 for 3-Tier formulary
• Tier 4 for 4-Tier formulary
• Tier 4 for Medicare Part D
Invokana
(canagliflozin)  
Continued coverage at
• Tier 3 for 3-Tier formulary
• Tier 4 for 4-Tier formulary
• Tier 4 for Medicare Part D

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

You’re Invited: Childhood Obesity Conference in Sept.

CLINICIAN CORNER

Prior Authorization Required for Immunobiologic Medications

Prior Authorization Required for Hyaluronate Injections for Osteoarthritis

Update of Cardiovascular Disease Risk Tests Policy

P&T Committee Updates

Specialty Pharmacy Updates

Screening for Eating Disorders in the Primary Care Setting

OFFICE ASSISTANT

Update: Durable Medical Equipment Payment Policy

New Medical Policy for Pulse Oximeters

Changes to Dialysis Network

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator